Holdings of T. Rowe Price Health Sciences Fund, Inc.
T. ROWE PRICE HEALTH SCIENCES FUND, INC. ·168 declared positions · as of Mar 31, 2026
Original filing · Net assets 10.9B $ · Ten largest lines: 42.2 % of the equity sleeve
Sector breakdown
- Health care 67.2 %
- Industrials 0.7 %
- Materials 0.5 %
- Consumer discretionary 0.2 %
- Unattributed 31.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 97.8 %
- HKD 1.3 %
- JPY 0.6 %
- CHF 0.2 %
- EUR 0.1 %
The quoted currency of each line, as declared.
Country breakdown
- US 88.3 %
- GB 3.4 %
- NL 3.3 %
- BM 1.4 %
- HK 1.3 %
- JP 0.6 %
- KY 0.5 %
- FR 0.5 %
- CH 0.2 %
- DK 0.2 %
- SG 0.2 %
- VG 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 148 | 9B $ | 88.34 % |
| 2 | GB | 2 | 348.8M $ | 3.43 % |
| 3 | NL | 3 | 332.1M $ | 3.26 % |
| 4 | BM | 2 | 138M $ | 1.36 % |
| 5 | HK | 1 | 129.2M $ | 1.27 % |
| 6 | JP | 1 | 62.9M $ | 0.62 % |
| 7 | KY | 4 | 55.2M $ | 0.54 % |
| 8 | FR | 2 | 53.5M $ | 0.53 % |
| 9 | CH | 1 | 24.1M $ | 0.24 % |
| 10 | DK | 1 | 16.4M $ | 0.16 % |
| 11 | SG | 1 | 15.3M $ | 0.15 % |
| 12 | VG | 1 | 10.4M $ | 0.10 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 1,200,478 | 1.1B $ | 10.14 % |
| 2 | Thermo Fisher Scientific Inc | 900,979 | 442.9M $ | 4.07 % |
| 3 | Intuitive Surgical Inc | 863,221 | 397.9M $ | 3.65 % |
| 4 | Stryker Corp | 1,147,522 | 377.1M $ | 3.46 % |
| 5 | Merck & Co Inc | 3,116,392 | 374.9M $ | 3.44 % |
| 6 | AstraZeneca PLC | 1,751,235 | 345.4M $ | 3.17 % |
| 7 | UnitedHealth Group Inc | 1,242,865 | 336.3M $ | 3.09 % |
| 8 | Argenx SE | 435,310 | 317.9M $ | 2.92 % |
| 9 | AbbVie Inc | 1,423,341 | 309.6M $ | 2.84 % |
| 10 | Regeneron Pharmaceuticals, Inc. | 373,226 | 288.4M $ | 2.65 % |
| 11 | Gilead Sciences Inc | 2,034,836 | 283.6M $ | 2.60 % |
| 12 | Johnson & Johnson | 1,088,355 | 266M $ | 2.44 % |
| 13 | Vertex Pharmaceuticals Inc | 591,295 | 264M $ | 2.42 % |
| 14 | Danaher Corp | 1,175,471 | 222.9M $ | 2.05 % |
| 15 | Alnylam Pharmaceuticals Inc | 531,894 | 176M $ | 1.62 % |
| 16 | Revolution Medicines Inc | 1,519,722 | 147.8M $ | 1.36 % |
| 17 | United Therapeutics Corp | 246,943 | 146.4M $ | 1.34 % |
| 18 | BeOne Medicines Ltd | 5,757,796 | 129.2M $ | 1.19 % |
| 19 | Roivant Sciences Ltd | 4,447,673 | 123.2M $ | 1.13 % |
| 20 | Protagonist Therapeutics Inc | 1,142,059 | 120.4M $ | 1.11 % |
| 21 | Insmed Inc | 702,695 | 114.9M $ | 1.05 % |
| 22 | Summit Therapeutics Inc | 5,948,323 | 112.8M $ | 1.04 % |
| 23 | Natera Inc | 561,746 | 112.3M $ | 1.03 % |
| 24 | Tenet Healthcare Corp | 580,102 | 109.5M $ | 1.00 % |
| 25 | BrightSpring Health Services Inc | 2,514,077 | 107.1M $ | 0.98 % |
| 26 | Amgen Inc | 303,722 | 106.9M $ | 0.98 % |
| 27 | Boston Scientific Corp | 1,603,771 | 100.6M $ | 0.92 % |
| 28 | HCA Healthcare Inc | 206,215 | 97.6M $ | 0.90 % |
| 29 | Guardant Health Inc | 1,055,988 | 97.5M $ | 0.90 % |
| 30 | CVS Health Corp | 1,310,339 | 94.1M $ | 0.86 % |
| 31 | Kymera Therapeutics Inc | 1,002,367 | 83.5M $ | 0.77 % |
| 32 | Cigna Group/The | 300,304 | 80.1M $ | 0.74 % |
| 33 | CG oncology Inc | 1,108,573 | 75M $ | 0.69 % |
| 34 | Cardinal Health, Inc. | 348,232 | 73.6M $ | 0.68 % |
| 35 | Elevance Health Inc | 244,278 | 71.5M $ | 0.66 % |
| 36 | Krystal Biotech Inc | 273,451 | 70.6M $ | 0.65 % |
| 37 | Scholar Rock Holding Corp | 1,369,780 | 67.3M $ | 0.62 % |
| 38 | Ionis Pharmaceuticals Inc | 882,823 | 66.3M $ | 0.61 % |
| 39 | Bridgebio Pharma Inc | 864,149 | 64.2M $ | 0.59 % |
| 40 | Chugai Pharmaceutical Co Ltd | 1,141,000 | 62.9M $ | 0.58 % |
| 41 | Structure Therapeutics Inc | 1,273,207 | 61.4M $ | 0.56 % |
| 42 | Praxis Precision Medicines Inc | 189,301 | 61M $ | 0.56 % |
| 43 | Celcuity Inc | 531,000 | 60.6M $ | 0.56 % |
| 44 | Royalty Pharma PLC | 1,241,743 | 59.6M $ | 0.55 % |
| 45 | Cencora Inc | 179,717 | 56.5M $ | 0.52 % |
| 46 | CENTESSA PHARMACEUTICALS PLC | 1,367,577 | 54.3M $ | 0.50 % |
| 47 | Vera Therapeutics Inc | 1,235,806 | 49.7M $ | 0.46 % |
| 48 | Nuvalent Inc | 459,791 | 47.1M $ | 0.43 % |
| 49 | Apogee Therapeutics Inc | 555,098 | 46.7M $ | 0.43 % |
| 50 | Abivax SA | 407,954 | 45.4M $ | 0.42 % |
| 51 | Edwards Lifesciences Corp | 562,277 | 45M $ | 0.41 % |
| 52 | Cytokinetics Inc | 663,136 | 43.7M $ | 0.40 % |
| 53 | Incyte Corp | 460,840 | 43.4M $ | 0.40 % |
| 54 | Spyre Therapeutics Inc | 854,145 | 43.1M $ | 0.40 % |
| 55 | Dianthus Therapeutics Inc | 482,750 | 40.5M $ | 0.37 % |
| 56 | Crinetics Pharmaceuticals Inc | 1,094,456 | 39.8M $ | 0.36 % |
| 57 | Tenax Therapeutics Inc | 2,481,066 | 39.7M $ | 0.36 % |
| 58 | Madrigal Pharmaceuticals Inc | 74,723 | 39.1M $ | 0.36 % |
| 59 | Immunome Inc | 1,665,614 | 36.4M $ | 0.33 % |
| 60 | IQVIA Holdings Inc | 207,553 | 35.4M $ | 0.32 % |
| 61 | Kodiak Sciences Inc | 921,511 | 35.1M $ | 0.32 % |
| 62 | Caris Life Sciences Inc | 1,909,867 | 34.1M $ | 0.31 % |
| 63 | Belite Bio Inc | 207,862 | 33.1M $ | 0.30 % |
| 64 | Monte Rosa Therapeutics Inc | 1,869,110 | 30.7M $ | 0.28 % |
| 65 | Terns Pharmaceuticals Inc | 557,042 | 29.4M $ | 0.27 % |
| 66 | Axsome Therapeutics Inc | 163,910 | 27.7M $ | 0.25 % |
| 67 | Moderna Inc | 527,555 | 26.8M $ | 0.25 % |
| 68 | Alumis Inc | 1,188,623 | 26.2M $ | 0.24 % |
| 69 | Beam Therapeutics Inc | 1,093,992 | 26.1M $ | 0.24 % |
| 70 | Alignment Healthcare Inc | 1,475,585 | 26M $ | 0.24 % |
| 71 | West Pharmaceutical Services Inc | 97,625 | 24.5M $ | 0.22 % |
| 72 | Sonova Holding AG | 105,533 | 24.1M $ | 0.22 % |
| 73 | Revvity Inc | 274,277 | 24M $ | 0.22 % |
| 74 | IDEXX Laboratories Inc | 42,552 | 23.9M $ | 0.22 % |
| 75 | Oruka Therapeutics Inc | 476,018 | 23.3M $ | 0.21 % |
| 76 | ORIC Pharmaceuticals Inc | 1,740,383 | 22.1M $ | 0.20 % |
| 77 | Sionna Therapeutics Inc | 547,443 | 21.9M $ | 0.20 % |
| 78 | MBX Biosciences Inc | 721,309 | 21.5M $ | 0.20 % |
| 79 | McKesson Corp | 24,522 | 21.2M $ | 0.19 % |
| 80 | Rhythm Pharmaceuticals Inc | 241,658 | 21M $ | 0.19 % |
| 81 | Billiontoone Inc | 264,475 | 20.9M $ | 0.19 % |
| 82 | Mirum Pharmaceuticals Inc | 224,930 | 20.8M $ | 0.19 % |
| 83 | Erasca Inc | 1,247,913 | 20.2M $ | 0.19 % |
| 84 | Immunocore Holdings PLC | 643,368 | 19.4M $ | 0.18 % |
| 85 | Palvella Therapeutics Inc | 153,120 | 19.1M $ | 0.18 % |
| 86 | Arrowhead Pharmaceuticals Inc | 301,270 | 18.9M $ | 0.17 % |
| 87 | Nurix Therapeutics Inc | 1,215,025 | 18.8M $ | 0.17 % |
| 88 | Rapport Therapeutics Inc | 601,105 | 18.8M $ | 0.17 % |
| 89 | Vaxcyte Inc | 314,645 | 18.3M $ | 0.17 % |
| 90 | Centene Corp | 529,331 | 17.3M $ | 0.16 % |
| 91 | Bio-Rad Laboratories Inc | 60,717 | 16.9M $ | 0.16 % |
| 92 | MoonLake Immunotherapeutics | 887,029 | 16.5M $ | 0.15 % |
| 93 | Novo Nordisk A/S | 446,869 | 16.4M $ | 0.15 % |
| 94 | WaVe Life Sciences Ltd | 2,107,233 | 15.3M $ | 0.14 % |
| 95 | Kestra Medical Technologies Ltd | 744,410 | 14.8M $ | 0.14 % |
| 96 | Stoke Therapeutics Inc | 452,134 | 14.7M $ | 0.14 % |
| 97 | Encompass Health Corp | 151,360 | 14.6M $ | 0.13 % |
| 98 | BEONE MEDICINES LTD | 49,225 | 14.6M $ | 0.13 % |
| 99 | Charles River Laboratories International Inc | 79,633 | 13.7M $ | 0.13 % |
| 100 | Celldex Therapeutics Inc | 422,316 | 13.4M $ | 0.12 % |